Clinical Trial Update: Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effects of dapagliflozin on microvascular and macrovascular circulation and total body sodium content in adults with type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED